Suppr超能文献

关于潜在创新型卫生技术的价格决定因素及定价政策:一项范围综述

Price determinants and pricing policies concerning potentially innovative health technologies: a scoping review.

作者信息

Xander Nicolas S H, Belleman Tom, Salcher-Konrad Maximilian, Hendrickx Anne, Chen Jeffrey, Klein Gebbink Anne-Sophie, Schneider Peter, Morgan Kate, Groene Oliver, Durand-Zaleski Isabelle, Thielen Frederick W, Uyl-de Groot Carin A

机构信息

Erasmus School of Health Policy & Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands.

Erasmus Centre for Health Economics Rotterdam, Erasmus University Rotterdam, Rotterdam, The Netherlands.

出版信息

Eur J Health Econ. 2025 Sep 6. doi: 10.1007/s10198-025-01834-y.

Abstract

BACKGROUND

Policymakers face challenges in developing pricing policies for potentially innovative healthcare technologies (pIHTs) that balance limited budgets, access, and incentives for innovation. This study aimed to map existing evidence and identify knowledge gaps regarding price determinants and pricing policies for pIHTs and their effect on access and sustainability.

METHODS

We conducted a scoping Review of scientific and grey literature in English published between 2014 and September 2023 with pre-specified inclusion and exclusion criteria to identify stakeholder-informed price determinants, pricing policies applied by European Economic Area (EEA) or Organisation for Economic Cooperation and Development (OECD) member states, and their access-related impacts. Literature databases and various stakeholder organisation websites were searched. Further records were included through snowballing and manual addition.

RESULTS

135 Records were included. Stakeholder views on price determinants were available from 15 records and predominantly involved value-based determinants. Pricing policies in EEA/OECD member states are heterogeneous and often feature a mix of policy interventions and implementation methods. External price referencing (EPR), while yielding short-term affordability improvements, is associated with price inequities and launch strategies impairing patient access. Policies combining pricing methods and considering a pIHT's value have more positive access-related impact but may face feasibility and implementation challenges. Two records mentioned medical device pricing; none featured environmental aspects.

CONCLUSION

While EPR is commonly applied across Europe, value-informed pricing in connection with health technology assessment is more favoured regarding pIHT access in the literature. Knowledge gaps concern medical device pricing, stakeholder views on price determinants, and the implementation of environmental aspects in pIHT pricing.

摘要

背景

政策制定者在为具有潜在创新性的医疗技术(pIHTs)制定定价政策时面临挑战,需要在有限预算、可及性和创新激励之间取得平衡。本研究旨在梳理现有证据,识别关于pIHTs价格决定因素、定价政策及其对可及性和可持续性影响的知识空白。

方法

我们对2014年至2023年9月期间以英文发表的科学文献和灰色文献进行了范围综述,采用预先设定的纳入和排除标准,以确定利益相关者所提供的价格决定因素、欧洲经济区(EEA)或经济合作与发展组织(OECD)成员国应用的定价政策及其与可及性相关的影响。检索了文献数据库和各利益相关者组织的网站。通过滚雪球法和手动添加纳入了更多记录。

结果

共纳入135条记录。15条记录提供了利益相关者对价格决定因素的看法,主要涉及基于价值的决定因素。EEA/OECD成员国的定价政策各不相同,通常具有多种政策干预措施和实施方法的组合。外部价格参考(EPR)虽然能在短期内提高可承受性,但与价格不平等以及损害患者可及性的上市策略相关。将定价方法与考虑pIHT的价值相结合的政策对可及性有更积极的影响,但可能面临可行性和实施方面的挑战。两条记录提到了医疗设备定价;均未涉及环境方面。

结论

虽然EPR在欧洲普遍应用,但在文献中,与卫生技术评估相关的基于价值的定价在pIHT可及性方面更受青睐。知识空白涉及医疗设备定价、利益相关者对价格决定因素的看法以及pIHT定价中环境方面的实施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验